Verseau Therapeutics


Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors.

Industries

Employees

11-50

Links


Org chart

Tatiana Novobrantseva
Co-Founder & Chief Scientific Officer
Lou Vaickus
Chief Medical Officer
Susan Low
Vice President

Board & advisors

Daniel Anderson
Board Member
Jong Chang
Board Member
Wen Chen
Board Member
Robert Langer
Board Member
Anna Turetsky
Board Member
Seung Min Yang
Board Member
Zhenping Zhu
Board Member


Offices